Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$34.05 – $37.43
0% from low
Exchange
OTC Link
OS
KOBAYASHI PHARM CO ORD
No one on the platform currently holds KBYPF.
No tracked institution reports a position in KBYPF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-12-31 | $61.0000 | |
| 2026-06-30 | $45.0000 | 2026-09-03 |
| 2025-12-31 | $60.0000 | 2026-03-09 |
| 2025-06-30 | $44.0000 | 2025-09-04 |
| 2024-12-31 | $59.0000 | 2025-03-14 |
| 2024-06-28 | $43.0000 | 2024-09-05 |
| 2023-12-29 | $58.0000 | 2024-03-07 |
No one on the platform has traded KBYPF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $176.8B | +6.8% | $140.17 | $137.67–$142.26 | 0.2× | 1 |
| 2027 | $184.2B | +4.2% | $186.80 | $183.47–$189.58 | 0.2× | 1 |
| 2028 | $191.2B | +3.8% | $230.71 | $226.60–$234.15 | 0.1× | 1 |
| 2029 | $193.3B | +1.1% | $242.15 | $237.83–$245.75 | 0.1× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $0.15 | $0.01 | -94.5% |
| 2026-05-08 | $0.03 | $0.09 | +159.3% |
| 2026-02-10 | $0.52 | $-0.27 | -151.8% |
| 2025-11-11 | $0.30 | $0.33 | +11.5% |
| 2025-06-30 | $0.17 | $0.14 | -14.0% |
| 2025-03-31 | $0.33 | $0.15 | -55.0% |
| 2024-12-31 | $0.50 | $0.40 | -18.7% |
| 2024-09-30 | $0.57 |
| $0.35 |
| -38.3% |
| +0.00% |
| $2.1B |
| — |
| LIOPFLion Corporation | $11.51 | +0.00% | $3.2B | — |
| MIOFFMilbon Co., Ltd. | $52.60 | +0.00% | $1.7B | — |
Source: Financial Modeling Prep · peers by sector/industry